QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Paper on cardiovascular event rates co-authored by Quantify has been published
The paper “Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data”, co-authored by Quantify’s Maria Lindh, Jonas Banefelt, and Sara Hallberg, has been published in European Heart Journal – Quality of Care and Clinical Outcomes. See full article here.
Quantify team co-authors paper on imminent fracture risk
The paper “Risk of imminent fracture following a previous fracture in a Swedish database study”, co-authored by Quantify’s Jonas Banefelt, Linda Karlsson, Oskar Ström, and Gustaf Ortsäter, has been published in Osteoporosis International. See full article here.
Thank you to all of you who particpated at our ISPOR course “Analysis of Longitudinal Data: Fixed and Random Effects Models”
On November 10, Kirk and Anders led the ISPOR course “Analysis of Longitudinal Data: Fixed and Random Effects Models”.
We would like to thank all of you who participated for making it a highly interactive session, and for contributing to the interesting discussions that followed!
Are you looking to inform your decisions using real world data? […]